Cargando…
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely underst...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579047/ https://www.ncbi.nlm.nih.gov/pubmed/28860506 http://dx.doi.org/10.1038/s41598-017-09256-4 |
_version_ | 1783260627627671552 |
---|---|
author | Ochi, Tsunehiro Kawaguchi, Takumi Nakahara, Takashi Ono, Masafumi Noguchi, Shuhei Koshiyama, Yuichi Munekage, Kensuke Murakami, Eisuke Hiramatsu, Akira Ogasawara, Mitsunari Hirose, Akira Mizuta, Hiroshi Masuda, Kosei Okamoto, Nobuto Suganuma, Narufumi Chayama, Kazuaki Yamaguchi, Masahiro Torimura, Takuji Saibara, Toshiji |
author_facet | Ochi, Tsunehiro Kawaguchi, Takumi Nakahara, Takashi Ono, Masafumi Noguchi, Shuhei Koshiyama, Yuichi Munekage, Kensuke Murakami, Eisuke Hiramatsu, Akira Ogasawara, Mitsunari Hirose, Akira Mizuta, Hiroshi Masuda, Kosei Okamoto, Nobuto Suganuma, Narufumi Chayama, Kazuaki Yamaguchi, Masahiro Torimura, Takuji Saibara, Toshiji |
author_sort | Ochi, Tsunehiro |
collection | PubMed |
description | Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely understood. To clarify these differences, patients with NAFLD (n = 37) and C-CH (n = 40) were evaluated with a continuous glucose monitoring system (CGMS). In the patients with NAFLD, Maximum blood glucose concentration and blood glucose swings were significantly correlated with hepatic fibrosis markers. In the patients with C-CH, however, those two CGMS parameters were negatively correlated with the serum albumin (ALB) concentration. Furthermore, in the patients with C-CH with an ALB concentration of ≤4.0 g/dl, those two CGMS parameters were negatively correlated with the ALB concentration with greater statistical significance. In conclusion, obvious differences in the characteristics of glucose intolerance between patients with NAFLD and those with C-CH were clarified. In patients with NAFLD, glucose intolerance gradually progressed in accordance with the progression of hepatic fibrosis. In those with C-CH, glucose intolerance suddenly developed upon the appearance of hypoalbuminaemia. |
format | Online Article Text |
id | pubmed-5579047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55790472017-09-06 Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS Ochi, Tsunehiro Kawaguchi, Takumi Nakahara, Takashi Ono, Masafumi Noguchi, Shuhei Koshiyama, Yuichi Munekage, Kensuke Murakami, Eisuke Hiramatsu, Akira Ogasawara, Mitsunari Hirose, Akira Mizuta, Hiroshi Masuda, Kosei Okamoto, Nobuto Suganuma, Narufumi Chayama, Kazuaki Yamaguchi, Masahiro Torimura, Takuji Saibara, Toshiji Sci Rep Article Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely understood. To clarify these differences, patients with NAFLD (n = 37) and C-CH (n = 40) were evaluated with a continuous glucose monitoring system (CGMS). In the patients with NAFLD, Maximum blood glucose concentration and blood glucose swings were significantly correlated with hepatic fibrosis markers. In the patients with C-CH, however, those two CGMS parameters were negatively correlated with the serum albumin (ALB) concentration. Furthermore, in the patients with C-CH with an ALB concentration of ≤4.0 g/dl, those two CGMS parameters were negatively correlated with the ALB concentration with greater statistical significance. In conclusion, obvious differences in the characteristics of glucose intolerance between patients with NAFLD and those with C-CH were clarified. In patients with NAFLD, glucose intolerance gradually progressed in accordance with the progression of hepatic fibrosis. In those with C-CH, glucose intolerance suddenly developed upon the appearance of hypoalbuminaemia. Nature Publishing Group UK 2017-08-31 /pmc/articles/PMC5579047/ /pubmed/28860506 http://dx.doi.org/10.1038/s41598-017-09256-4 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ochi, Tsunehiro Kawaguchi, Takumi Nakahara, Takashi Ono, Masafumi Noguchi, Shuhei Koshiyama, Yuichi Munekage, Kensuke Murakami, Eisuke Hiramatsu, Akira Ogasawara, Mitsunari Hirose, Akira Mizuta, Hiroshi Masuda, Kosei Okamoto, Nobuto Suganuma, Narufumi Chayama, Kazuaki Yamaguchi, Masahiro Torimura, Takuji Saibara, Toshiji Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title_full | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title_fullStr | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title_full_unstemmed | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title_short | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
title_sort | differences in characteristics of glucose intolerance between patients with nafld and chronic hepatitis c as determined by cgms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579047/ https://www.ncbi.nlm.nih.gov/pubmed/28860506 http://dx.doi.org/10.1038/s41598-017-09256-4 |
work_keys_str_mv | AT ochitsunehiro differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT kawaguchitakumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT nakaharatakashi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT onomasafumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT noguchishuhei differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT koshiyamayuichi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT munekagekensuke differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT murakamieisuke differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT hiramatsuakira differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT ogasawaramitsunari differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT hiroseakira differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT mizutahiroshi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT masudakosei differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT okamotonobuto differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT suganumanarufumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT chayamakazuaki differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT yamaguchimasahiro differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT torimuratakuji differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms AT saibaratoshiji differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms |